MEDP Medpace Holdings Inc

Price (delayed)

$397.52

Market cap

$12.23B

P/E Ratio

43.21

Dividend/share

N/A

EPS

$9.2

Enterprise value

$12.12B

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate ...

Highlights
Medpace Holdings's quick ratio has surged by 69% YoY and by 28% QoQ
Medpace Holdings's equity has increased by 45% YoY and by 19% from the previous quarter
The P/E is 55% higher than the last 4 quarters average of 27.9 and 42% higher than the 5-year quarterly average of 30.4
Medpace Holdings's gross margin has decreased by 6% YoY

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
30.76M
Market cap
$12.23B
Enterprise value
$12.12B
Valuations
Price to book (P/B)
21.82
Price to sales (P/S)
6.48
EV/EBIT
36.07
EV/EBITDA
31.73
EV/Sales
6.43
Earnings
Revenue
$1.89B
EBIT
$336.17M
EBITDA
$382.14M
Free cash flow
$396.73M
Per share
EPS
$9.2
Free cash flow per share
$12.91
Book value per share
$18.22
Revenue per share
$61.38
TBVPS
$31.2
Balance sheet
Total assets
$1.66B
Total liabilities
$1.1B
Debt
$142.12M
Equity
$558.95M
Working capital
-$331.3M
Liquidity
Debt to equity
0.25
Current ratio
0.64
Quick ratio
0.59
Net debt/EBITDA
-0.27
Margins
EBITDA margin
20.3%
Gross margin
27.8%
Net margin
15%
Operating margin
17.9%
Efficiency
Return on assets
19%
Return on equity
64%
Return on invested capital
N/A
Return on capital employed
45.9%
Return on sales
17.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
-1.39%
1 week
0.97%
1 month
31.91%
1 year
105.03%
YTD
29.68%
QTD
29.68%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$1.89B
Gross profit
$524.51M
Operating income
$336.83M
Net income
$282.81M
Gross margin
27.8%
Net margin
15%
MEDP's revenue is up by 29% year-on-year and by 6% since the previous quarter
The operating income has increased by 21% year-on-year and by 3.3% since the previous quarter
MEDP's gross profit is up by 21% year-on-year and by 4.2% since the previous quarter
The net income has increased by 15% YoY and by 3.5% from the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
P/E
43.21
P/B
21.82
P/S
6.48
EV/EBIT
36.07
EV/EBITDA
31.73
EV/Sales
6.43
The P/E is 55% higher than the last 4 quarters average of 27.9 and 42% higher than the 5-year quarterly average of 30.4
The EPS is up by 22% YoY and by 4.2% QoQ
MEDP's price to book (P/B) is 127% higher than its 5-year quarterly average of 9.6 and 28% higher than its last 4 quarters average of 17.0
Medpace Holdings's equity has increased by 45% YoY and by 19% from the previous quarter
MEDP's price to sales (P/S) is 51% more than its last 4 quarters average of 4.3 and 47% more than its 5-year quarterly average of 4.4
MEDP's revenue is up by 29% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Medpace Holdings business performance
The ROS is down by 9% YoY
The company's return on equity fell by 7% QoQ but it rose by 6% YoY
Medpace Holdings's return on assets has increased by 3.3% YoY but it has decreased by 2.1% QoQ

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 51% higher than its total liabilities
Medpace Holdings's quick ratio has surged by 69% YoY and by 28% QoQ
Medpace Holdings's current ratio has surged by 52% YoY and by 21% QoQ
The debt is 75% smaller than the equity
MEDP's debt to equity is down by 49% year-on-year and by 17% since the previous quarter
Medpace Holdings's equity has increased by 45% YoY and by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.